Vimarsana
Biggest News Aggregation in the World

Page 3 - Adv Chronic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adv Chronic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adv Chronic Today - Breaking & Trending Today

Frontiers | Reversible Bronchiectasis in COVID-19 Survivors With Acute Respiratory Distress Syndrome: Pseudobronchiectasis - Vimarsana News

Frontiers | Reversible Bronchiectasis in COVID-19 Survivors With Acute Respiratory Distress Syndrome: Pseudobronchiectasis

To retrospectively analyze whether traction bronchiectasis was reversible in coronavirus disease 2019 (COVID-19) survivors with acute respiratory distress syndrome (ARDS) and whether CT findings were associated with the reversibility, 41 COVID-19 survivors with ARDS were followed up for more than four months. Demographics, clinical data, and all chest CT images were collected. The follow-up CT images were compared with the previous CT scans. Twenty-eight (68%) patients with traction bronchiectasis (Group I) and 13 (32%) patients without traction bronchiectasis (Group II) on CT images. Traction...

Janssen: New Subgroup Analysis of the Phase 3 OPTIMUM Study Demonstrates the Benefits of PONVORYTM? (ponesimod) Over teriflunomide in Early Disease Multiple Sclerosis - Vimarsana News

Janssen: New Subgroup Analysis of the Phase 3 OPTIMUM Study Demonstrates the Benefits of PONVORYTM? (ponesimod) Over teriflunomide in Early Disease Multiple Sclerosis

Early treatment in multiple sclerosis (MS) with higher-potency therapies can improve long-term patient outcomes1,2 New subgroup analysis of the pivotal Phase 3 OPTIMUM trial shows that MS patients